Short answer
ACTUATE THERAPEUTICS, INC. (ACTU) filed its Q2 2026 10-Q quarterly report on Aug 14, 2026 for the quarter ended Jun 30, 2026.
Q2 2026 key financials · XBRL
- Net income
- −$5M
- +18.2% YoY · +13.5% QoQ
- EPS (diluted)
- −$0.20
- +35.5% YoY · +16.7% QoQ
Source: XBRL data from the ACTUATE THERAPEUTICS, INC. (ACTU) Q2 2026 10-Q on SEC EDGAR. USD.
ACTUATE THERAPEUTICS, INC. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material risk-factor details provided beyond general investment-risk warning
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ACTUATE THERAPEUTICS, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.